Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.

Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA.

Depress Anxiety. 2012 Jul;29(7):587-96. doi: 10.1002/da.21969. Epub 2012 Jun 11.

PMID:
22689344
[PubMed - indexed for MEDLINE]
2.

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.

Janicak PG, Dunner DL, Aaronson ST, Carpenter LL, Boyadjis TA, Brock DG, Cook IA, Lanocha K, Solvason HB, Bonneh-Barkay D, Demitrack MA.

CNS Spectr. 2013 Dec;18(6):322-32. doi: 10.1017/S1092852913000357. Epub 2013 Jul 30.

PMID:
23895940
[PubMed - indexed for MEDLINE]
3.

Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.

Connolly KR, Helmer A, Cristancho MA, Cristancho P, O'Reardon JP.

J Clin Psychiatry. 2012 Apr;73(4):e567-73. doi: 10.4088/JCP.11m07413.

PMID:
22579164
[PubMed - indexed for MEDLINE]
4.

A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.

Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA.

J Clin Psychiatry. 2014 Dec;75(12):1394-401. doi: 10.4088/JCP.13m08977.

PMID:
25271871
[PubMed - in process]
Free Article
5.

H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.

Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y.

World J Biol Psychiatry. 2014 May;15(4):298-306. doi: 10.3109/15622975.2011.639802. Epub 2012 Feb 7.

PMID:
22313023
[PubMed - indexed for MEDLINE]
6.

Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.

Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE 3rd, George MS, Sackeim HA, Lisanby SH.

Depress Anxiety. 2012 Oct;29(10):883-90. doi: 10.1002/da.21967. Epub 2012 Jun 11.

PMID:
22689290
[PubMed - indexed for MEDLINE]
7.

Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.

Avery DH, Isenberg KE, Sampson SM, Janicak PG, Lisanby SH, Maixner DF, Loo C, Thase ME, Demitrack MA, George MS.

J Clin Psychiatry. 2008 Mar;69(3):441-51.

PMID:
18294022
[PubMed - indexed for MEDLINE]
8.

Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.

Rosenquist PB, Krystal A, Heart KL, Demitrack MA, McCall WV.

Psychiatry Res. 2013 Jan 30;205(1-2):67-73. doi: 10.1016/j.psychres.2012.09.011. Epub 2012 Sep 25.

PMID:
23021320
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.

O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA.

Biol Psychiatry. 2007 Dec 1;62(11):1208-16. Epub 2007 Jun 14.

PMID:
17573044
[PubMed - indexed for MEDLINE]
10.

Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 1.

PMID:
23074457
[PubMed]
Free PMC Article
11.

Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.

Simpson KN, Welch MJ, Kozel FA, Demitrack MA, Nahas Z.

Adv Ther. 2009 Mar;26(3):346-68. doi: 10.1007/s12325-009-0013-x. Epub 2009 Mar 28. Erratum in: Adv Ther. 2009 Jul;26(7):737.

PMID:
19330495
[PubMed - indexed for MEDLINE]
12.

Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.

Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP.

J Clin Psychiatry. 2011 Oct;72(10):1376-82. doi: 10.4088/JCP.09m05888blu.

PMID:
21295002
[PubMed - indexed for MEDLINE]
13.

[Management strategies for major depressive episodes as a function of initial response to an SSRI or SNRI antidepressant: results of the ORACLE survey].

Spadone C, Sylvestre M, Chiarelli P, Richard-Berthe C.

Encephale. 2005 Nov-Dec;31(6 Pt 1):698-704. French.

PMID:
16462689
[PubMed - indexed for MEDLINE]
14.

A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.

Avery DH, Holtzheimer PE 3rd, Fawaz W, Russo J, Neumaier J, Dunner DL, Haynor DR, Claypoole KH, Wajdik C, Roy-Byrne P.

Biol Psychiatry. 2006 Jan 15;59(2):187-94. Epub 2005 Sep 1.

PMID:
16139808
[PubMed - indexed for MEDLINE]
15.

Repetitive transcranial magnetic stimulation treats postpartum depression.

Garcia KS, Flynn P, Pierce KJ, Caudle M.

Brain Stimul. 2010 Jan;3(1):36-41. doi: 10.1016/j.brs.2009.06.001. Epub 2009 Jul 8.

PMID:
20633429
[PubMed - indexed for MEDLINE]
16.

Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression.

Aguirre I, Carretero B, Ibarra O, Kuhalainen J, Martínez J, Ferrer A, Salva J, Roca M, Gili M, Montoya P, Garcia-Toro M.

J Affect Disord. 2011 May;130(3):466-9. doi: 10.1016/j.jad.2010.10.038. Epub 2010 Nov 18.

PMID:
21093060
[PubMed - indexed for MEDLINE]
17.

An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients.

Demirtas-Tatlidede A, Mechanic-Hamilton D, Press DZ, Pearlman C, Stern WM, Thall M, Pascual-Leone A.

J Clin Psychiatry. 2008 Jun;69(6):930-4.

PMID:
18505308
[PubMed - indexed for MEDLINE]
18.

Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment.

Janicak PG, O'Reardon JP, Sampson SM, Husain MM, Lisanby SH, Rado JT, Heart KL, Demitrack MA.

J Clin Psychiatry. 2008 Feb;69(2):222-32.

PMID:
18232722
[PubMed - indexed for MEDLINE]
19.

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.

Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF.

Brain Stimul. 2010 Oct;3(4):187-99. doi: 10.1016/j.brs.2010.07.003. Epub 2010 Aug 11.

PMID:
20965447
[PubMed - indexed for MEDLINE]
20.

[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].

Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.

Encephale. 2009 Dec;35(6):595-604. doi: 10.1016/j.encep.2009.10.011. Epub . French.

PMID:
20004291
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk